Inquis Medical, a medical device company pioneering advanced treatments for venous thromboembolic disease, today announced the U.S. commercial launch of the latest AVENTUS™ Catheter, designed to ...

The Food and Drug Administration (FDA) has approved the Autus Size-Adjustable Valve (Edward Lifesciences) for pediatric patients with congenital heart ...

In the United Kingdom, 2.9% of patients undergoing anesthesia reported receiving glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study published online Sept. 16 in Anaesthesia to ...

Despite having an implantable cardioverter-defibrillator, a 62-year-old woman suffered from ongoing atrial fibrillation and ...

Children with congenital heart disease outgrow their replacement valves, requiring repeat open-heart surgeries. The Autus can ...

Children born with certain heart defects may face fewer open-heart surgeries, thanks to a new replacement valve that grows ...

Edwards Lifesciences (NYSE: EW) today announced that the U.S. Food and Drug Administration (FDA) has approved the AUTUS Size-Adjustable Valve, a surgical pulmonary valve designed specifically for ...

FDA-approved AUTUS heart valve expands inside a child's body as they grow, potentially reducing repeat open-heart surgeries for pulmonary valve disease.

The surgical Autus valve is designed to accommodate growth through a minimally invasive transcatheter procedure.

Edwards Lifesciences Corp. EW on Thursday gained U.S. Food and Drug Administration clearance for its AUTUS Size-Adjustable Valve, offering a specialized surgical option for pediatric patients needing ...

The valve can be implanted at about 13 millimeters in diameter to fit a toddler or preschool-age child and widened to reach 22 millimeters, which is comparable to an adult pulmona ...

The Autus surgically implanted device, made by Edwards Lifesciences, is also novel for its leaflets consisting of ePTFE.